Researcher.Life Logo

Expert Opinion on Drug Metabolism and Toxicology : Impact Factor & More

eISSN: 1744-7607pISSN: 1742-5255

Aims and Scope of Expert Opinion on Drug Metabolism and Toxicology

Expert Opinion on Drug Metabolism & Toxicology is a monthly peer-reviewed medical journal publishing review articles on ADME-Tox. It was established in 2005 and is published by Taylor and Francis. The editor-in-chief is Luis Valerio (Food and Drug Administration). Less

Key Metrics

CiteScore
7.2
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q1Toxicology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Drug Metabolism and Toxicology

Expert Opinion on Drug Metabolism and Toxicology Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Drug Metabolism and Toxicology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Drug Metabolism and Toxicology

Clinical, toxicological and pharmacokinetic data of emerging drugs for the treatment of atherosclerosis: are they promising?
  • 3 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
How can we overcome the pharmacokinetic challenges posed when conducting complex DDI studies?
  • 16 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Exploring the influence of sex on idiosyncratic DILI: impact on risk assessment
  • 13 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
New insights into the role of CYP26 in retinoic acid clearance
  • 4 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Sex differences and impact of age-based menopausal status on tacrolimus pharmacokinetics: results of the TransplantLines biobank and cohort study
  • 4 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Rethinking pharmacokinetics in preterm and term neonates and infants: sex as a critical biological variable
  • 4 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Clinical, toxicological and pharmacokinetic data of emerging drugs for the treatment of atherosclerosis: are they promising?
  • 3 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
How can we overcome the pharmacokinetic challenges posed when conducting complex DDI studies?
  • 16 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Exploring the influence of sex on idiosyncratic DILI: impact on risk assessment
  • 13 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
New insights into the role of CYP26 in retinoic acid clearance
  • 4 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Sex differences and impact of age-based menopausal status on tacrolimus pharmacokinetics: results of the TransplantLines biobank and cohort study
  • 4 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Rethinking pharmacokinetics in preterm and term neonates and infants: sex as a critical biological variable
  • 4 May 2026
  • Expert Opinion on Drug Metabolism & Toxicology

FAQs on Expert Opinion on Drug Metabolism and Toxicology